A phase II study of capecitabine plus oxaliplatin (XELOX): a new first-line option in metastatic colorectal cancer (Q33366181)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase II study of capecitabine plus oxaliplatin (XELOX): a new first-line option in metastatic colorectal cancer |
scientific article |
Statements
1 reference
A phase II study of capecitabine plus oxaliplatin (XELOX): a new first-line option in metastatic colorectal cancer (English)
1 reference
George Fountzilas
1 reference
Thomas Makatsoris
1 reference
Haralabos P Kalofonos
1 reference
Gerasimos Aravantinos
1 reference
Christos Papadimitriou
1 reference
Efstathios Kastritis
1 reference
Sotirios K Rigatos
1 reference
Nikolaos Xiros
1 reference
Theodore Petsas
1 reference
Theofanis Economopoulos
1 reference
Athanassios K Sakadamis
1 reference
Hellenic Cooperative Oncology Group
1 reference
1 January 2005
1 reference
1 reference
35
1 reference
103-109
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference